A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

Roy Tarnuzzer(University of Central Florida), Ashton C. Berger(University of Florida), Ina Felau(National Cancer Institute), Sobia Zaidi(George Washington University), Visweswaran Ravikumar(The University of Texas MD Anderson Cancer Center), Colm J. O’Rourke(University of Copenhagen), Heidi J. Sofia, André Schultz, Kazufumi Ohshiro(George Washington University), Andrew D. Cherniack(Broad Institute), Xubin Li(The University of Texas MD Anderson Cancer Center), Rupa S. Kanchi(The University of Texas MD Anderson Cancer Center), Jesper B. Andersen(University of Copenhagen), Arjun Pennathur(University of Pittsburgh Medical Center), Jason Roszik(The University of Texas MD Anderson Cancer Center), Shoujun Gu, Melpomeni Kasapi, John A. Demchok(National Cancer Institute), Lawrence N. Kwong(The University of Texas MD Anderson Cancer Center), Simon Shelley(University of Wisconsin–Madison), Carolyn M. Hutter(National Human Genome Research Institute), Jaffer A. Ajani(The University of Texas MD Anderson Cancer Center), Martin L. Ferguson(National Cancer Institute), Jian Chen(The University of Texas MD Anderson Cancer Center), Hatice U. Osmanbeyoglu(Memorial Sloan Kettering Cancer Center), Shuyun Rao(George Washington University), Yuexin Liu(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center), Nancy R. Gough(George Washington University), Rory Johnson(University College Dublin), Philip L. Lorenzi(City Of Hope National Medical Center), Linda Resar(Johns Hopkins University), Jiexin Zhang(The University of Texas MD Anderson Cancer Center), Wilma Jogunoori(George Washington University), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Sendurai A. Mani(Brown University), Arvind Rao(Washtenaw Community College), Maciej Wiznerowicz(International Institute for Molecular Oncology), Gordon Robertson(BC Cancer Agency), Zhenlin Ju(The University of Texas MD Anderson Cancer Center), Guillermo de Velasco(Dana-Farber Cancer Institute), Wencai Ma(The University of Texas MD Anderson Cancer Center), Pan Tong(The University of Texas MD Anderson Cancer Center), Andres Houseman(Oregon State University), Bao‐Ngoc Nguyen(George Washington University Hospital), Shiyun Ling(Guangzhou University of Chinese Medicine), Donna E. Hansel(The University of Texas MD Anderson Cancer Center), Mike Datto(Duke University)
Cell Systems
September 26, 2018
Cited by 193


Related Papers